title: Nasopharyngeal cancer.
abstract: The current standards of treatment for nasopharyngeal cancer include 1. In early disease (stage I and stage II), radiotherapy is the treatment of choice, and the chance for cure is usually high. 2. In locally advanced disease (stage III and stage IV) combination chemotherapy and radiation therapy is indicated. Further clinical trials are warranted, which may include the newer active chemotherapeutic agents. 3. Patients with distant metastases may be treated with chemotherapy alone or other palliative measures.
authors.affiliation: Department of Medicine, Providence Hospital, Southfield, Michigan, USA.
authors.forename: H
authors.initials: H
authors.lastname: Ali
authors.forename: M
authors.initials: M
authors.lastname: al-Sarraf
mesh_terms: D017024:Chemotherapy, Adjuvant; D003937:Diagnosis, Differential; D014943:Global Health; D006801:Humans; D009303:Nasopharyngeal Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D009367:Neoplasm Staging; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic; D016019:Survival Analysis; D016896:Treatment Outcome